Literature DB >> 22105074

Evolutionarily conserved residues at glucagon-like peptide-1 (GLP-1) receptor core confer ligand-induced receptor activation.

Mi Jin Moon1, Hee Young Kim, Sumi Park, Dong-Kyu Kim, Eun Bee Cho, Cho Rong Park, Dong-Joo You, Jong-Ik Hwang, Kyungjin Kim, Han Choe, Jae Young Seong.   

Abstract

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) play important roles in insulin secretion through their receptors, GLP1R and GIPR. Although GLP-1 and GIP are attractive candidates for treatment of type 2 diabetes and obesity, little is known regarding the molecular interaction of these peptides with the heptahelical core domain of their receptors. These core domains are important not only for specific ligand binding but also for ligand-induced receptor activation. Here, using chimeric and point-mutated GLP1R/GIPR, we determined that evolutionarily conserved amino acid residues such as Ile(196) at transmembrane helix 2, Leu(232) and Met(233) at extracellular loop 1, and Asn(302) at extracellular loop 2 of GLP1R are responsible for interaction with ligand and receptor activation. Application of chimeric GLP-1/GIP peptides together with molecular modeling suggests that His(1) of GLP-1 interacts with Asn(302) of GLP1R and that Thr(7) of GLP-1 has close contact with a binding pocket formed by Ile(196), Leu(232), and Met(233) of GLP1R. This study may provide critical clues for the development of peptide and/or nonpeptide agonists acting at GLP1R.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22105074      PMCID: PMC3281735          DOI: 10.1074/jbc.M111.276808

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Glucagon and GLP-1 receptors: lessons from chimeric ligands and receptors.

Authors:  S A Hjorth; T W Schwartz
Journal:  Acta Physiol Scand       Date:  1996-07

2.  The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors.

Authors:  P Gourlet; J P Vilardaga; P De Neef; M Waelbroeck; A Vandermeers; P Robberecht
Journal:  Peptides       Date:  1996       Impact factor: 3.750

3.  GLP-1/GIP chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1.

Authors:  B Gallwitz; M Witt; C Morys-Wortmann; U R Fölsch; W E Schmidt
Journal:  Regul Pept       Date:  1996-05-07

4.  The amino terminal domain of the glucagon-like peptide-1 receptor is a critical determinant of subtype specificity.

Authors:  M P Graziano; P J Hey; C D Strader
Journal:  Recept Channels       Date:  1996

5.  Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. Evidence for a common pattern of ligand-receptor interaction.

Authors:  C Bergwitz; T J Gardella; M R Flannery; J T Potts; H M Kronenberg; S R Goldring; H Jüppner
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

6.  The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro.

Authors:  Søren Bregenholt; Annette Møldrup; Niels Blume; Allan E Karlsen; Birgitte Nissen Friedrichsen; Ditte Tornhave; Lotte Bjerre Knudsen; Jacob S Petersen
Journal:  Biochem Biophys Res Commun       Date:  2005-05-06       Impact factor: 3.575

7.  Five out of six tryptophan residues in the N-terminal extracellular domain of the rat GLP-1 receptor are essential for its ability to bind GLP-1.

Authors:  A Wilmen; B Van Eyll; B Göke; R Göke
Journal:  Peptides       Date:  1997       Impact factor: 3.750

Review 8.  GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.

Authors:  Tanya Hansotia; Daniel J Drucker
Journal:  Regul Pept       Date:  2005-06-15

9.  Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin.

Authors:  E Di Paolo; P De Neef; N Moguilevsky; H Petry; A Bollen; M Waelbroeck; P Robberecht
Journal:  FEBS Lett       Date:  1998-03-13       Impact factor: 4.124

10.  The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity.

Authors:  A Wilmen; B Göke; R Göke
Journal:  FEBS Lett       Date:  1996-11-25       Impact factor: 4.124

View more
  13 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.

Authors:  M Dong; C Koole; D Wootten; P M Sexton; L J Miller
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 3.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

4.  Functional Pairing of Class B1 Ligand-GPCR in Cephalochordate Provides Evidence of the Origin of PTH and PACAP/Glucagon Receptor Family.

Authors:  Jason S W On; Cumming Duan; Billy K C Chow; Leo T O Lee
Journal:  Mol Biol Evol       Date:  2015-04-03       Impact factor: 16.240

5.  Ligand binding pocket formed by evolutionarily conserved residues in the glucagon-like peptide-1 (GLP-1) receptor core domain.

Authors:  Mi Jin Moon; Yoo-Na Lee; Sumi Park; Arfaxad Reyes-Alcaraz; Jong-Ik Hwang; Robert Peter Millar; Han Choe; Jae Young Seong
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

6.  Molecular Coevolution of Neuropeptides Gonadotropin-Releasing Hormone and Kisspeptin with their Cognate G Protein-Coupled Receptors.

Authors:  Dong-Kyu Kim; Eun Bee Cho; Mi Jin Moon; Sumi Park; Jong-Ik Hwang; Jean-Luc Do Rego; Hubert Vaudry; Jae Young Seong
Journal:  Front Neurosci       Date:  2012-01-24       Impact factor: 4.677

7.  Polymorphisms of GLP-1 receptor gene and response to GLP-1 analogue in patients with poorly controlled type 2 diabetes.

Authors:  Chia-Hung Lin; Yun-Shien Lee; Yu-Yao Huang; Sheng-Hwu Hsieh; Zih-Syuan Chen; Chi-Neu Tsai
Journal:  J Diabetes Res       Date:  2015-02-15       Impact factor: 4.011

8.  A novel glucagon-related peptide (GCRP) and its receptor GCRPR account for coevolution of their family members in vertebrates.

Authors:  Cho Rong Park; Mi Jin Moon; Sumi Park; Dong-Kyu Kim; Eun Bee Cho; Robert Peter Millar; Jong-Ik Hwang; Jae Young Seong
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

9.  Structural and molecular conservation of glucagon-like Peptide-1 and its receptor confers selective ligand-receptor interaction.

Authors:  Mi Jin Moon; Sumi Park; Dong-Kyu Kim; Eun Bee Cho; Jong-Ik Hwang; Hubert Vaudry; Jae Young Seong
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-19       Impact factor: 5.555

10.  A Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and β-Cell Growth.

Authors:  Hee Young Kim; Jong-Ik Hwang; Mi Jin Moon; Jae Young Seong
Journal:  Endocrinol Metab (Seoul)       Date:  2014-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.